Bone Biopsy Market Set to Witness Significant Growth by 2026-2033

The Global Bone Biopsy Market is estimated to be valued at USD 772.6 Million in 2025 and is expected to reach USD 1,177.2 Million by 2032.

Published on Feb. 11, 2026

Got story updates? Submit your updates here. ›

The Global Bone Biopsy Market is estimated to be valued at USD 772.6 Million in 2025 and is expected to reach USD 1,177.2 Million by 2032. This study delivers key insights, clear segmentation and actionable intelligence to help decision-makers navigate the evolving Bone Biopsy Market and capitalize on upcoming opportunities.

Why it matters

The Bone Biopsy Market is being reshaped by rapid innovation, rising investment and shifting regional dynamics. This report provides strategic coverage of investment hotspots, regional trend shifts and emerging segments to help businesses capitalize on upcoming opportunities in the Bone Biopsy Market.

The details

The Global Bone Biopsy Market is segmented by Procedure Type (Closed (Percutaneous) Biopsy and Open Biopsy), Application (Cancer Diagnosis, Bone Infection Diagnosis, Metabolic Bone Disorders), Product Type (Needle Biopsy, Bone Biopsy Kits, Biopsy Guns), Guidance Technology (Ultrasound-Guided, CT-Guided, MRI-Guided, Fluoroscopy or X-ray Guided), and End User (Hospitals, Diagnostic Laboratories, Specialty Clinics, Ambulatory Surgical Centers). The report covers expert review of past performance, current trends and anticipated developments, as well as analysis of production/consumption patterns, supply-demand dynamics, pricing and margin outlook.

  • The Global Bone Biopsy Market is estimated to be valued at USD 772.6 Million in 2025.
  • The Global Bone Biopsy Market is expected to reach USD 1,177.2 Million by 2032.

The players

BD (Becton, Dickinson and Company)

A leading global medical technology company that develops and manufactures medical devices, instrument systems, and reagents.

Medtronic

A global healthcare technology company that develops and manufactures medical devices and therapies to treat a variety of medical conditions.

Abbott Laboratories

A global healthcare company that develops and manufactures a broad range of medical devices, diagnostic products, and branded generic pharmaceuticals.

Stryker Corporation

A global medical technology company that offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine.

Olympus Corporation

A global technology company that specializes in the manufacture of optics and reprography equipment.

Got photos? Submit your photos here. ›

The takeaway

The Bone Biopsy Market is undergoing significant transformation driven by rapid innovation, rising investment, and shifting regional dynamics. This report provides strategic insights and actionable intelligence to help businesses capitalize on the evolving opportunities in this market.